Alzex Neuropharma Inc (TRRI)
Alzex Neuropharma Inc. (OTC Markets: TRRI) is a common stock listing of a development-stage biopharmaceutical company focused on therapies for Alzheimer’s disease and other neurological disorders. The company was incorporated in 1971 and is based in Las Vegas, Nevada. It operated previously under the name Trinity Resources Inc. before adopting its current name in December 2022. As an OTC Markets-listed common equity, the security represents ownership in the company rather than a fund, debt instrument, or other listed product.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-TRRI
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
0.602 K
|
